Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy

Journal of Acquired Immune Deficiency Syndromes

Volumn 25, Issue 4, 2000, Pages 312-321

  Mynarcik, Dennis C ^a   McNurlan, Margaret A ^b   Steigbigel, Roy T ^a   Fuhrer, Jack ^a   Gelato, Marie C ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Free fatty acid; HIV AIDS; Insulin resistance; Insulin like growth factor binding protein; Lipodystrophy; Obesity; Tumor necrosis factor ; Type 2 diabetes mellitus

Indexed keywords

FATTY ACID; SOMATOMEDIN BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; IMMUNE RESPONSE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LIPODYSTROPHY; LIPOGENESIS; MALE; MUSCLE ATROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0034492351     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200012010-00004     Document Type: Article

References (54)

1. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
2. "Buffalo hump" in men with HIV-1 infection
3. Visceral abdominal-fat accumulation associated with use of indinavir
4. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy
5. Pathophysiology of insulin resistance in human disease
6. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)
7. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
8. Insulin resistance in HIV protease inhibitor-associated diabetes
9. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection
10. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women
11. Studies of body composition and fat distribution in HIV-infected and control subjects
12. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial
13. Mechanisms of fatty acid-induced inhibition of glucose uptake
14. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men
15. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity
16. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus
17. Abdominal obesity
18. Metabolic implications of body fat distribution
19. Abdominal obesity and its metabolic complications: Implications for the risk of ischaemic heart disease
20. Insulin-like growth factor binding protein-1 in NIDDM: Relationship with the insulin resistance syndrome
21. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance
22. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance
23. Role of cytokines in AIDS wasting
24. The wasting syndrome in AIDS: Mechanisms and implications
25. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection
26. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
27. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team
28. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure
29. Glucose clamp technique: A method for quantifying insulin secretion and resistance
30. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity
31. Insulin sensitivity and serum triglyceride level in obese white and black women: Relationship to visceral and truncal subcutaneous fat
32. Associations between regional body fat distribution, fasting plasma free fatty acid levels and glucose tolerance in premenopausal women
33. Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes
34. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals
35. Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection
36. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance
37. Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus
38. Dose-response characteristics for effects of insulin on production and utilization of glucose in man
39. Insulin-mediated reduction of whole body protein breakdown. Dose-msponse effects on leucine metabolism in postabsorptive men
40. Laparoscopic cholecystectomy does not prevent the postoperative protein catabolic response in muscle
41. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man
42. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus
43. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity
44. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome
45. Insulin-like growth factor binding protein-1: Recent findings and new directions
46. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
47. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: Relation to insulin receptor phosphorylation and intra-cellular signalling through the insulin receptor substrate-1 pathway
48. Insulin resistance: The clinical spectrum
49. The IGF-I/IGFBP system in congenital partial lipodystrophy
50. Studies of insulin resistance in congenital generalized lipodystrophy
51. Generalized lipodystrophy, congenital and acquired (lipoatrophy)
52. Life without white fat: A transgenic mouse
53. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy